The European Medicines Agency (EMA) has recommended the approval of the Corona vaccine from Biontech/Pfizer, which has been adapted to the omicron variant, for children over the age of five. This was announced by the EMA in Amsterdam.
The experts expect broader protection against different corona variants. The manufacturers pointed to studies that found strong immune responses against subvariants BA.4 and BA.5 in people over 18 years of age 30 days after vaccination. The adapted vaccine is just as well tolerated and safe as the original preparation.